Archives for June 1, 2021

Corbus in licensing deal for monoclonal antibodies to tackle cancer and fibrotic diseases

Corbus Pharmaceuticals announced the expansion of its portfolio into immuno-oncology through licensing deals with the University of California San Francisco and Panorama Research Inc for two new monoclonal antibodies (mAbs).

Biogen and Bio-Thera’s Phase 3 study for arthritis biosimilar meets primary endpoints

A Phase 3 study of BAT1806, a proposed biosimilar referencing Actemra/RoActemra (tocilizumab), has shown equivalent efficacy and a comparable safety profile in patients with moderate-to-severe rheumatoid arthritis.

Moderna starts process to obtain BLA for Covid-19 shot

Moderna has initiated the rolling submission process with the US Food and Drug Administration (FDA) for a Biologics License Application (BLA) to distribute and market its mRNA COVID-19 vaccine in the US for use in individuals aged 18 and older.

BIO Digital 2021

Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment

The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drug’s effectiveness in preventing worsening of symptoms and hospitalization.

WHO assigns Greek letters to SARS-CoV-2 variants

The World Health Organization (WHO) is assigning ‘simple, easy to say and remember’ labels to key variants of SARS-CoV-2, using letters of the Greek alphabet.